Lynparza 150 mg film-coated tablets, IMFINZI 50 mg/mL concentrate for solution for infusion.
D9102C00001
Phase 2 small_molecule active
Quick answer
Lynparza 150 mg film-coated tablets, IMFINZI 50 mg/mL concentrate for solution for infusion. for Stage IV Non Small Cell Lung Cancer whose tumors lack EGFR mutations and ALK fusions is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Stage IV Non Small Cell Lung Cancer whose tumors lack EGFR mutations and ALK fusions
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active